Vitamin D and Cancer: An Unclear Relationship

Share this content:
According to the National Cancer Institute, there are not enough available data to establish whether taking vitamin D can prevent cancer.
According to the National Cancer Institute, there are not enough available data to establish whether taking vitamin D can prevent cancer.

Several recent studies attempted to determine the role of vitamin D supplementation in oncogenesis and cancer treatment. The relationship, however, remains unclear.

A study in the Journal of Clinical Oncology showed, for example, that a deficiency of serum 25-hydroxyvitamin D (25-OH D) increased the odds of adverse prostate cancer pathology among men with localized prostate cancer undergoing radical prostatectomy.1 Serum 25-OH D levels less than 30 ng/mL were associated with more than twice the risk of adverse pathology.

A systematic review of 7 studies of vitamin D and bladder cancer showed that vitamin D deficiency increased the risk of developing the disease (this was found in 5 of the 7 studies).2 Higher levels of vitamin D correlated with better survival and outcomes.

A pooled analysis published in PLoS One showed that 25 OH D concentrations of 40 ng/mL or greater were associated with a substantial risk reduction of all invasive cancers.3 The analysis used data from 2 cohorts including more than 2300 people with multiple cancer types. Women with concentrations of 40 ng/mL or greater had a 67% lower risk for cancer than women with concentrations less than 20 ng/mL.

RELATED: Vitamin D Deficiency Linked to Poor Breast Cancer Prognosis

Other studies have evaluated the role of vitamin D after a cancer diagnosis. JAMA Oncology recently published the results of a cohort study of 1666 women with breast cancer measuring the level of vitamin D in the blood at the time of breast cancer diagnosis.4 Higher serum 25-OH D levels were independently associated with better outcomes for patients, including longer overall survival. Compared with the lowest tertile of vitamin D levels, those women with the highest levels had a superior overall survival; this advantage was even greater among premenopausal women.

Page 1 of 2

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs